Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.

Development and evaluation of buccoadhesive tablet for selegiline hydrochloride based on thiolated polycarbophil.

Wasnik MN, Godse RD, Nair HA.

Drug Dev Ind Pharm. 2014 May;40(5):632-8. doi: 10.3109/03639045.2014.884124.

PMID:
24517570
2.

A novel formulation of selegiline for the treatment of Parkinson's disease.

Tetrud JW, Koller WC.

Neurology. 2004 Oct 12;63(7 Suppl 2):S2-6. Review. No abstract available.

PMID:
15477582
3.

Mucoadhesive and cohesive properties of poly(acrylic acid)-cysteine conjugates with regard to their molecular mass.

Leitner VM, Marschütz MK, Bernkop-Schnürch A.

Eur J Pharm Sci. 2003 Jan;18(1):89-96.

PMID:
12554077
4.

Development and in vivo evaluation of an oral delivery system for low molecular weight heparin based on thiolated polycarbophil.

Kast CE, Guggi D, Langoth N, Bernkop-Schnürch A.

Pharm Res. 2003 Jun;20(6):931-6.

PMID:
12817900
5.

Thiolated polycarbophil as an adjuvant for permeation enhancement in nasal delivery of antisense oligonucleotides.

Vetter A, Martien R, Bernkop-Schnürch A.

J Pharm Sci. 2010 Mar;99(3):1427-39. doi: 10.1002/jps.21887.

PMID:
19708062
6.

A new formulation of selegiline: improved bioavailability and selectivity for MAO-B inhibition.

Clarke A, Brewer F, Johnson ES, Mallard N, Hartig F, Taylor S, Corn TH.

J Neural Transm (Vienna). 2003 Nov;110(11):1241-55.

PMID:
14628189
7.

Thiolated polymers: development and evaluation of transdermal delivery systems for progesterone.

Valenta C, Walzer A, Clausen AE, Bernkop-Schnürch A.

Pharm Res. 2001 Feb;18(2):211-6.

PMID:
11405293
8.

In vitro evaluation of mucoadhesive vaginal tablets of antifungal drugs prepared with thiolated polymer and development of a new dissolution technique for vaginal formulations.

Baloglu E, Ay Senyıgıt Z, Karavana SY, Vetter A, Metın DY, Hilmioglu Polat S, Guneri T, Bernkop-Schnurch A.

Chem Pharm Bull (Tokyo). 2011;59(8):952-8.

9.

Development and in vitro evaluation of a mucoadhesive vaginal delivery system for nystatin.

Hombach J, Palmberger TF, Bernkop-Schnürch A.

J Pharm Sci. 2009 Feb;98(2):555-64. doi: 10.1002/jps.21457.

PMID:
18563796
10.

Development of controlled drug release systems based on thiolated polymers.

Bernkop-Schnürch A, Scholler S, Biebel RG.

J Control Release. 2000 May 3;66(1):39-48.

PMID:
10708877
11.

Synthesis of thiolated alginate and evaluation of mucoadhesiveness, cytotoxicity and release retardant properties.

Jindal AB, Wasnik MN, Nair HA.

Indian J Pharm Sci. 2010 Nov;72(6):766-74. doi: 10.4103/0250-474X.84590.

12.

In vitro evaluation of the permeation-enhancing effect of thiolated polycarbophil.

Clausen AE, Bernkop-Schnürch A.

J Pharm Sci. 2000 Oct;89(10):1253-61.

PMID:
10980500
13.

Polymer-cysteamine conjugates: new mucoadhesive excipients for drug delivery?

Kast CE, Bernkop-Schnürch A.

Int J Pharm. 2002 Mar 2;234(1-2):91-9.

PMID:
11839440
14.

Thiolated polycarbophil/glutathione: defining its potential as a permeation enhancer for oral drug administration in comparison to sodium caprate.

Perera G, Barthelmes J, Vetter A, Krieg C, Uhlschmied C, Bonn GK, Bernkop-Schnürch A.

Drug Deliv. 2011 Aug;18(6):415-23. doi: 10.3109/10717544.2011.570807.

PMID:
21554106
15.

A comprehensive in vitro and in vivo evaluation of thiolated matrix tablets as a gastroretentive delivery system.

Senyigit ZA, Vetter A, Guneri T, Bernkop-Schnürch A.

Drug Deliv. 2011 Aug;18(6):405-14. doi: 10.3109/10717544.2011.570806.

PMID:
21463156
16.

Development of buccal drug delivery systems based on a thiolated polymer.

Langoth N, Kalbe J, Bernkop-Schnürch A.

Int J Pharm. 2003 Feb 18;252(1-2):141-8.

PMID:
12550789
17.
18.

Synthesis and characterisation of mucoadhesive thiolated polymers.

Bernkop-Schnürch A, Steininger S.

Int J Pharm. 2000 Jan 25;194(2):239-47.

PMID:
10692648
19.

An oral oligonucleotide delivery system based on a thiolated polymer: Development and in vitro evaluation.

Martien R, Hoyer H, Perera G, Schnürch AB.

Eur J Pharm Biopharm. 2011 Aug;78(3):355-60. doi: 10.1016/j.ejpb.2011.01.016.

PMID:
21295141
20.

A new low-dose formulation of selegiline: clinical efficacy, patient preference and selectivity for MAO-B inhibition.

Clarke A, Johnson ES, Mallard N, Corn TH, Johnston A, Boyce M, Warrington S, MacMahon DG.

J Neural Transm (Vienna). 2003 Nov;110(11):1257-71.

PMID:
14628190
Items per page

Supplemental Content

Support Center